Status:
COMPLETED
Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Foundation for Informed Medical Decision Making
Olmsted Medical Center
Conditions:
Osteoporosis
Osteopenia
Eligibility:
FEMALE
50-90 years
Phase:
NA
Brief Summary
Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing...
Eligibility Criteria
Inclusion
- Peri and Postmenopausal Caucasian, Black, Hispanic and Asian women, aged 50-90
- Bone mineral density (BMD) T-Score \< 1.0
- Have appointment with clinician to discuss test results and treatment options
- Patients with FRAX \<20% risk who have taken a bisphosphonate for \< 5 years.
Exclusion
- Unable to speak or read English
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT00949611
Start Date
May 1 2009
End Date
February 1 2011
Last Update
February 2 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55901
2
Mayo Clinic
Rochester, Minnesota, United States, 55902